168 related articles for article (PubMed ID: 2494160)
1. Valproate in anxiety and withdrawal syndromes.
Roy-Byrne PP; Ward NG; Donnelly PJ
J Clin Psychiatry; 1989 Mar; 50 Suppl():44-8. PubMed ID: 2494160
[TBL] [Abstract][Full Text] [Related]
2. Valproate and carbamazepine in the treatment of panic and posttraumatic stress disorders, withdrawal states, and behavioral dyscontrol syndromes.
Keck PE; McElroy SL; Friedman LM
J Clin Psychopharmacol; 1992 Feb; 12(1 Suppl):36S-41S. PubMed ID: 1541716
[TBL] [Abstract][Full Text] [Related]
3. A role for valproate in the treatment of sedative-hypnotic withdrawal and for relapse prevention.
Harris JT; Roache JD; Thornton JE
Alcohol Alcohol; 2000; 35(4):319-23. PubMed ID: 10905994
[TBL] [Abstract][Full Text] [Related]
4. Anticonvulsant drugs in alcohol withdrawal: use of phenytoin, primidone, carbamazepine, valproic acid, and the sedative anticonvulsants.
Wilbur R; Kulik FA
Am J Hosp Pharm; 1981 Aug; 38(8):1138-43. PubMed ID: 6791497
[TBL] [Abstract][Full Text] [Related]
5. Carbamazepine and valproate as adjuncts in the treatment of alcohol withdrawal syndrome: a retrospective cohort study.
Eyer F; Schreckenberg M; Hecht D; Adorjan K; Schuster T; Felgenhauer N; Pfab R; Strubel T; Zilker T
Alcohol Alcohol; 2011; 46(2):177-84. PubMed ID: 21339186
[TBL] [Abstract][Full Text] [Related]
6. Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: vulnerability and effect of carbamazepine.
Klein E; Colin V; Stolk J; Lenox RH
Am J Psychiatry; 1994 Dec; 151(12):1760-6. PubMed ID: 7977882
[TBL] [Abstract][Full Text] [Related]
7. Preliminary evidence for the utility of carbamazepine in alprazolam withdrawal.
Klein E; Uhde TW; Post RM
Am J Psychiatry; 1986 Feb; 143(2):235-6. PubMed ID: 2868666
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive review of the psychiatric uses of valproate.
Davis LL; Ryan W; Adinoff B; Petty F
J Clin Psychopharmacol; 2000 Feb; 20(1 Suppl 1):1S-17S. PubMed ID: 10646685
[TBL] [Abstract][Full Text] [Related]
9. Review: Adjunctive pharmacologic approaches for benzodiazepine tapers.
Welsh JW; Tretyak V; McHugh RK; Weiss RD; Bogunovic O
Drug Alcohol Depend; 2018 Aug; 189():96-107. PubMed ID: 29906718
[TBL] [Abstract][Full Text] [Related]
10. Novel anticonvulsants in the treatment of alcoholism.
Book SW; Myrick H
Expert Opin Investig Drugs; 2005 Apr; 14(4):371-6. PubMed ID: 15882114
[TBL] [Abstract][Full Text] [Related]
11. Update on anticonvulsants for the treatment of alcohol withdrawal.
Malcolm R; Myrick H; Brady KT; Ballenger JC
Am J Addict; 2001; 10(s1):s16-s23. PubMed ID: 11268817
[TBL] [Abstract][Full Text] [Related]
12. Pregabalin in benzodiazepine withdrawal.
Biermann T; Bleich S; Kornhuber J; Hillemacher T
Pharmacopsychiatry; 2007 Nov; 40(6):292-3. PubMed ID: 18030656
[No Abstract] [Full Text] [Related]
13. Use of anticonvulsants in benzodiazepine withdrawal.
Pages KP; Ries RK
Am J Addict; 1998; 7(3):198-204. PubMed ID: 9702287
[TBL] [Abstract][Full Text] [Related]
14. Anticonvulsants for neuropathic pain and detoxification.
Covington EC
Cleve Clin J Med; 1998; 65 Suppl 1():SI21-9; discussion SI45-7. PubMed ID: 12033203
[TBL] [Abstract][Full Text] [Related]
15. Valproate treatment of alcohol withdrawal and mania.
Hammer BA; Brady KT
Am J Psychiatry; 1996 Sep; 153(9):1232. PubMed ID: 8780434
[No Abstract] [Full Text] [Related]
16. [Carbamazepine in the treatment of alcohol withdrawal].
Wolańczyk T; Wojnar M; Cedro A
Psychiatr Pol; 1997; 31(2):189-96. PubMed ID: 9527664
[TBL] [Abstract][Full Text] [Related]
17. [The comparison of tianeptine and carbamazepine in benzodiazepines withdrawal symptoms].
Kornowski J
Psychiatr Pol; 2002; 36(6 Suppl):311-8. PubMed ID: 12647454
[TBL] [Abstract][Full Text] [Related]
18. Prevention of alcohol withdrawal seizures with carbamazepine and valproic acid.
Hillbom M; Tokola R; Kuusela V; Kärkkäinen P; Källi-Lemma L; Pilke A; Kaste M
Alcohol; 1989; 6(3):223-6. PubMed ID: 2500138
[TBL] [Abstract][Full Text] [Related]
19. Treatment of alcohol withdrawal syndrome with combined carbamazepine and tiapride in a patient with probable sleep apnoe syndrome.
Gartenmaier A; Pelzer E; Soyka M
Pharmacopsychiatry; 2005 Mar; 38(2):96-8. PubMed ID: 15744634
[TBL] [Abstract][Full Text] [Related]
20. Anticonvulsant drugs in the treatment of substance withdrawal.
Zullino DF; Khazaal Y; Hättenschwiler J; Borgeat F; Besson J
Drugs Today (Barc); 2004 Jul; 40(7):603-19. PubMed ID: 15510234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
